Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Feb-24 5:52 PM View:  | Third Rock Ventures Iv, L.P. 10% Owner | Tango Therapeutics, Inc. (TNGX) | 20-Feb-24 | Private Sale | 162,500 | $12.00 | $1,950,000.00 | (< 1%) 19.36M to 19.2M | |
| 08-Feb-24 9:08 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 1,817 | $12.62 | $22,930.20 | (1%) 134.21K to 132.4K | |
| 08-Feb-24 9:09 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 1,354 | $12.62 | $17,087.20 | (3%) 45.34K to 43.98K | |
| 08-Feb-24 9:04 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 4,083 | $12.62 | $51,526.60 | (3%) 123.56K to 119.48K | |
| 08-Feb-24 9:14 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 07-Feb-24 | Sale | 4,457 | $12.62 | $56,246.40 | (< 1%) 1.54M to 1.54M | |
| 08-Feb-24 9:09 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 1,422 | $12.56 | $17,864.00 | (3%) 46.76K to 45.34K | |
| 08-Feb-24 9:04 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 4,288 | $12.56 | $53,868.40 | (3%) 127.85K to 123.56K | |
| 08-Feb-24 9:14 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 4,681 | $12.56 | $58,805.50 | (< 1%) 1.54M to 1.54M | |
| 08-Feb-24 9:08 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 06-Feb-24 | Private Sale | 1,908 | $12.56 | $23,969.40 | (1%) 136.12K to 134.21K | |
| 05-Feb-24 4:19 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 22,859 | -- | -- | 100% 0 to 22.86K | |
| 05-Feb-24 4:27 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 39,413 | -- | -- | 100% 0 to 39.41K | |
| 05-Feb-24 4:21 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 87,168 | -- | -- | 100% 0 to 87.17K | |
| 05-Feb-24 4:22 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 01-Feb-24 | Grant | 46,599 | -- | -- | 100% 0 to 46.6K | |
| 02-Nov-23 4:49 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 01-Nov-23 | Sale | 7,507 | $8.39 | $62,994.20 | (8%) 88.76K to 81.25K | |
| 17-Oct-23 6:04 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 16-Oct-23 | Purchase | 500,000 | $6.84 | $3,420,000.00 | 3% 15.41M to 15.91M | |
| 17-Oct-23 6:04 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 13-Oct-23 | Private Purchase | 750,000 | $7.07 | $5,302,500.00 | 5% 14.66M to 15.41M | |
| 11-Oct-23 9:22 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 50,000 | $9.91 | $495,500.00 | (< 1%) 14.89M to 14.84M | (3%) |
| 11-Oct-23 9:22 PM View: | Boxer Capital, LLC | Tango Therapeutics, Inc. (TNGX) | 09-Oct-23 | Market Sale | 175,000 | $9.97 | $1,744,750.00 | (1%) 14.84M to 14.66M | (2%) |
| 31-Aug-23 4:07 PM View: | Ketchum John B Director | Tango Therapeutics, Inc. (TNGX) | 29-Aug-23 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 15-Aug-23 9:34 PM View: | Boxer Capital, LLC Director | Tango Therapeutics, Inc. (TNGX) | 11-Aug-23 | Private Purchase | 475,000 | $5.15 | $2,446,250.00 | 3% 14.41M to 14.89M | |
| 08-Jun-23 9:33 PM View: | Peters Malte Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 08-Jun-23 9:39 PM View: | Calhoun Lesley Ann Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 08-Jun-23 9:34 PM View: | Huber Reid M Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 08-Jun-23 9:40 PM View: | Rothenberg MacE Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 08-Jun-23 9:32 PM View: | Davis Aaron I. Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | < 1% 14.38M to 14.39M | |
| 08-Jun-23 9:36 PM View: | Borisy Alexis Director | Tango Therapeutics, Inc. (TNGX) | 06-Jun-23 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 02-Mar-23 4:06 PM View: | Barry Douglas General Counsel | Tango Therapeutics, Inc. (TNGX) | 01-Mar-23 | Grant | 23,898 | -- | -- | 100% 0 to 23.9K | |
| 02-Mar-23 4:10 PM View: | Crystal Adam See Remarks | Tango Therapeutics, Inc. (TNGX) | 01-Mar-23 | Grant | 81,250 | -- | -- | 100% 0 to 81.25K | |
| 02-Mar-23 4:06 PM View: | Beckman Daniella Chief Financial Officer | Tango Therapeutics, Inc. (TNGX) | 01-Mar-23 | Grant | 32,842 | -- | -- | 51% 63.87K to 96.71K | |
| 02-Mar-23 4:05 PM View: | Huang Alan Chief Scientific Officer | Tango Therapeutics, Inc. (TNGX) | 01-Mar-23 | Grant | 31,697 | -- | -- | 23% 135.89K to 167.58K | |
| 02-Mar-23 4:06 PM View: | Weber Barbara Chief Executive Officer Director | Tango Therapeutics, Inc. (TNGX) | 01-Mar-23 | Grant | 89,545 | -- | -- | 7% 1.37M to 1.46M | |
| 13-Oct-22 9:30 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 13-Oct-22 | Purchase | 70,000 | $4.65 | $325,227.00 | < 1% 7.32M to 7.39M | |
| 13-Oct-22 9:30 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 12-Oct-22 | Purchase | 50,000 | $4.43 | $221,640.00 | < 1% 7.27M to 7.32M | |
| 13-Oct-22 9:30 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 11-Oct-22 | Private Purchase | 117,000 | $4.25 | $497,706.00 | 2% 7.16M to 7.27M | |
| 06-Oct-22 9:15 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 06-Oct-22 | Purchase | 70,394 | $4.06 | $286,067.00 | 1% 6.98M to 7.05M | |
| 06-Oct-22 9:15 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 05-Oct-22 | Purchase | 86,000 | $3.88 | $334,053.00 | 1% 6.9M to 6.98M | |
| 06-Oct-22 9:15 PM View: | Boxer Capital, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 04-Oct-22 | Private Purchase | 25,606 | $3.67 | $93,976.60 | < 1% 6.87M to 6.9M | |
| 24-Nov-20 9:30 PM View: | Bctg Holdings, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 20-Nov-20 | Sale | 5,000 | $0.01 | $30.00 | (< 1%) 4.49M to 4.49M | |
| 10-Sep-20 7:33 PM View: | Bctg Holdings, LLC 10% Owner | Tango Therapeutics, Inc. (TNGX) | 08-Sep-20 | Purchase | 533,500 | $10.00 | $5,335,000.00 | 13% 3.96M to 4.49M |
